Disturbing News for Xanax XR Users: Recall Underway

A specific lot of the anti-anxiety medication Xanax XR is being recalled across the country following quality control issues. The distributor, Viatris Specialty LLC, initiated the voluntary action after tablets failed essential dissolution testing.

These tests measure how quickly a pill releases its active ingredients once ingested. If a drug fails to dissolve correctly, it may not maintain the necessary effectiveness or dosage consistency for the patient.

Health Points

• The recall affects 3-milligram Xanax XR bottles of 60 tablets with lot number 8177156 and an expiration date of February 28, 2027.
• The FDA categorized this as a Class II recall, meaning the product could cause temporary health issues, though serious consequences are unlikely.
• Patients holding the affected medication should stop use immediately and dispose of the pills safely.

The FDA issued this notice to ensure patients treating panic disorders receive reliable and consistent medication levels. The specific lot was distributed between August 2024 and May 2025.

Read the Full Article